Coagulation and fibrinolytic parameters in normal pregnancy and in pregnancy complicated by intrauterine growth retardation

American Journal of Perinatology

Volumn 15, Issue 2, 1998, Pages 81-85

  Bellart, Jordi ^a   Gilabert, Rosa ^b   Fontcuberta, Jordi ^c   Carreras, Elena ^c   Miralles, Ramon M ^a   Cabero, Lluis ^c  

^a HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^b UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Coagulation; Fibrinolysis; Intrauterine growth retardation; Pregnancy

Indexed keywords

ANTITHROMBIN III; D DIMER; HEPARIN COFACTOR II; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; PROTEIN C; PROTEIN S; THROMBIN ANTITHROMBIN COMPLEX; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD EXAMINATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; HUMAN; HYPERCOAGULABILITY; INTRAUTERINE GROWTH RETARDATION; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL;

EID: 0031900649     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-993903     Document Type: Article

References (17)

1. Wallenburg HCS, Van Kessel. Platelet life span in pregnancies resulting in small-for-gestational age infants. Am J Obstet Gynecol 1979;134:739-742
2. Elder MG, Myatt L. Coagulation and fibrinolysis in pregnancies complicated by fetal growth retardation. Br J Obstet Gynaecol 1976;83:355-360
3. Ballegeer VC, Mombaerts P, Declerck PJ, et al. Fibrinolytic response to venous occlusion and fibrin fragment D-dimer levels in normal and complicated pregnancy Thromb Haemost 1987;58:1030-1032
4. Bonnar J, Daly L, Sheppard BL. Changes in the fibrinolytic system during pregnancy. Sem Thromb Hemost 1990; 16:221-229
5. Estellés A, Gilabert J, España F, Aznar J, Galbis M. Fibrinolytic parameters in normotensive pregnancy with intrauterine fetal growth retardation and in severe preeclampsia. Am J Obstet Gynecol 1991;165:138-142
6. Lindoff C, Astedt B. Plasminogen activator of urokinase type and its inhibitor of plascental type in hypertensive pregnancies and in intrauterine growth retardation possible markers of placental function. Am J Obstet Gynecol 1994;171:60-64
7. Estelles A, Gilabert J, Keeton M, Eguchi Y, Aznar J, Grancha S, España F, Loskutoff DJ, Schleef RR. Altered expression of plasminogen activator inhibitor type I in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation. Blood 1994;84: 143-150
8. Grancha S, Estelles A, Gilabert J, Chirivella M, España F, Aznar J. Decreased expression of PAI-2 mRNA and protein in pregnancies complicated with intrauterine fetal growth retardation. Thromb Haemost 1996;76:761-767
9. He S, Bremme K, Almqvist I, Blomback M. Decrease in plasminogen activator inhibitor type 2 related more to placental function and intrauterine fetal growth than to severity of preeclampsia. Hyper Preg 1996;15:171-182
10. Andrew M, Mitchell L, Berry L, et al. An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus. J Clin Invest 1992;89:321-326
11. Liu L, Dewar L, Song Y, Kulczycky M, Blajchman MA, Fenton JW, Andrew M, Delorme M, Ginsberg J, et al. Inhibition of thrombin by antithrombm III and heparin cofactor II in vivo. Thromb Haemost 1995;73:405-412
12. España F, Hendl S, Aznar J, Gilabert J, Estelles A. Determination of total, free and complexed protein S in plasma by ELISA and comparison with a standard electroimmunoassay. Thromb Res 1991;62:613-624
13. Bremme K, Östlund E, Almqvist I, Heinonen K, Blombäck M. Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium. Obstet Gynecol 1992;80:132-137
14. Bellart J, Gilabert R, Fontcuberta J, Borrell M, Miralles RM, Cabero L. Fibrinolysis changes in normal pregnancy. J Perinat Med 1997;25:368-72
15. Gilabert J, Estelles A, Ayuso MJ, España F, Chirivella M, Grancha S, Mico JM, Aznar J. Evaluation of plasminogen activators and plasminogen activator inhibitors in plasma and amniotic fluid in pregnancies complicated with intrauterin fetal growth. Gynecol Obstet Invest 1994;38: 157-162
16. Dickinson JL, Bates EJ, Ferrante A, Antalis TM. Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis. Evidence for an alternate biological function. J Biol Chem 1995;270:27894-27904
17. Bachmann F. The enigma PAI-2. Gene expression, evolutionary and functional aspects. Thromb Haemost 1995; 74:172-179